BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 37045996)

  • 1. Evolutionary characterization of lung adenocarcinoma morphology in TRACERx.
    Karasaki T; Moore DA; Veeriah S; Naceur-Lombardelli C; Toncheva A; Magno N; Ward S; Bakir MA; Watkins TBK; Grigoriadis K; Huebner A; Hill MS; Frankell AM; Abbosh C; Puttick C; Zhai H; Gimeno-Valiente F; Saghafinia S; Kanu N; Dietzen M; Pich O; Lim EL; Martínez-Ruiz C; Black JRM; Biswas D; Campbell BB; Lee C; Colliver E; Enfield KSS; Hessey S; Hiley CT; Zaccaria S; Litchfield K; Birkbak NJ; Cadieux EL; Demeulemeester J; Van Loo P; Adusumilli PS; Tan KS; Cheema W; Sanchez-Vega F; Jones DR; Rekhtman N; Travis WD; Hackshaw A; Marafioti T; Salgado R; Le Quesne J; Nicholson AG; ; McGranahan N; Swanton C; Jamal-Hanjani M
    Nat Med; 2023 Apr; 29(4):833-845. PubMed ID: 37045996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-grade lung adenocarcinomas with micropapillary and/or solid patterns: a review.
    Morales-Oyarvide V; Mino-Kenudson M
    Curr Opin Pulm Med; 2014 Jul; 20(4):317-23. PubMed ID: 24852329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic Genomics and Clinical Features of Lung Adenocarcinoma: A Retrospective Study.
    Shi J; Hua X; Zhu B; Ravichandran S; Wang M; Nguyen C; Brodie SA; Palleschi A; Alloisio M; Pariscenti G; Jones K; Zhou W; Bouk AJ; Boland J; Hicks B; Risch A; Bennett H; Luke BT; Song L; Duan J; Liu P; Kohno T; Chen Q; Meerzaman D; Marconett C; Laird-Offringa I; Mills I; Caporaso NE; Gail MH; Pesatori AC; Consonni D; Bertazzi PA; Chanock SJ; Landi MT
    PLoS Med; 2016 Dec; 13(12):e1002162. PubMed ID: 27923066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolution of lung cancer and impact of subclonal selection in TRACERx.
    Frankell AM; Dietzen M; Al Bakir M; Lim EL; Karasaki T; Ward S; Veeriah S; Colliver E; Huebner A; Bunkum A; Hill MS; Grigoriadis K; Moore DA; Black JRM; Liu WK; Thol K; Pich O; Watkins TBK; Naceur-Lombardelli C; Cook DE; Salgado R; Wilson GA; Bailey C; Angelova M; Bentham R; Martínez-Ruiz C; Abbosh C; Nicholson AG; Le Quesne J; Biswas D; Rosenthal R; Puttick C; Hessey S; Lee C; Prymas P; Toncheva A; Smith J; Xing W; Nicod J; Price G; Kerr KM; Naidu B; Middleton G; Blyth KG; Fennell DA; Forster MD; Lee SM; Falzon M; Hewish M; Shackcloth MJ; Lim E; Benafif S; Russell P; Boleti E; Krebs MG; Lester JF; Papadatos-Pastos D; Ahmad T; Thakrar RM; Lawrence D; Navani N; Janes SM; Dive C; Blackhall FH; Summers Y; Cave J; Marafioti T; Herrero J; Quezada SA; Peggs KS; Schwarz RF; Van Loo P; Miedema DM; Birkbak NJ; Hiley CT; Hackshaw A; Zaccaria S; ; Jamal-Hanjani M; McGranahan N; Swanton C
    Nature; 2023 Apr; 616(7957):525-533. PubMed ID: 37046096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic mapping of metastatic organotropism in lung adenocarcinoma.
    Lengel HB; Mastrogiacomo B; Connolly JG; Tan KS; Liu Y; Fick CN; Dunne EG; He D; Lankadasari MB; Satravada BA; Sun Y; Kundra R; Fong C; Smith S; Riely GJ; Rudin CM; Gomez DR; Solit DB; Berger MF; Li BT; Mayo MW; Matei I; Lyden DC; Adusumilli PS; Schultz N; Sanchez-Vega F; Jones DR
    Cancer Cell; 2023 May; 41(5):970-985.e3. PubMed ID: 37084736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome.
    Solis LM; Behrens C; Raso MG; Lin HY; Kadara H; Yuan P; Galindo H; Tang X; Lee JJ; Kalhor N; Wistuba II; Moran CA
    Cancer; 2012 Jun; 118(11):2889-99. PubMed ID: 22020674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [To evaluate the clinicopathologic characteristics and outcome of tumor cells spreading through air spaces in patients with adenocarcinoma of lung].
    Sun PL; Liu JN; Cao LQ; Yao M; Gao HW
    Zhonghua Bing Li Xue Za Zhi; 2017 May; 46(5):303-308. PubMed ID: 28468034
    [No Abstract]   [Full Text] [Related]  

  • 8. The cribriform pattern identifies a subset of acinar predominant tumors with poor prognosis in patients with stage I lung adenocarcinoma: a conceptual proposal to classify cribriform predominant tumors as a distinct histologic subtype.
    Kadota K; Yeh YC; Sima CS; Rusch VW; Moreira AL; Adusumilli PS; Travis WD
    Mod Pathol; 2014 May; 27(5):690-700. PubMed ID: 24186133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors of acinar- or papillary-predominant adenocarcinoma of the lung.
    Kim M; Chung YS; Kim KA; Shim HS
    Lung Cancer; 2019 Nov; 137():129-135. PubMed ID: 31586770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenomic profiling of lung adenocarcinoma reveals poorly differentiated tumors are associated with an immunogenic tumor microenvironment.
    Akhave N; Zhang J; Bayley E; Frank M; Chiou SH; Behrens C; Chen R; Hu X; Parra ER; Lee WC; Swisher S; Solis L; Weissferdt A; Moran C; Kalhor N; Zhang J; Scheet P; Vaporciyan AA; Sepesi B; Gibbons DL; Heymach JV; Lee JJ; Wistuba II; Andrew Futreal P; Zhang J; Fujimoto J; Reuben A
    Lung Cancer; 2022 Oct; 172():19-28. PubMed ID: 35973335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Underlying Tumor Genomics of Predominant Histologic Subtypes in Lung Adenocarcinoma.
    Caso R; Sanchez-Vega F; Tan KS; Mastrogiacomo B; Zhou J; Jones GD; Nguyen B; Schultz N; Connolly JG; Brandt WS; Bott MJ; Rocco G; Molena D; Isbell JM; Liu Y; Mayo MW; Adusumilli PS; Travis WD; Jones DR
    J Thorac Oncol; 2020 Dec; 15(12):1844-1856. PubMed ID: 32791233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SMARCA4-deficient pulmonary adenocarcinoma: clinicopathological, immunohistochemical, and molecular characteristics of a novel aggressive neoplasm with a consistent TTF1
    Agaimy A; Fuchs F; Moskalev EA; Sirbu H; Hartmann A; Haller F
    Virchows Arch; 2017 Nov; 471(5):599-609. PubMed ID: 28555282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic landscape of metastatic lung adenocarcinomas from large-scale clinical sequencing.
    Li D; Huang Y; Cai L; Wu M; Bao H; Xu Y; Wei Y; Wu S; Wu X; Shao Y; Zhao W; Lv G; Huang S; Zhang T; Shi Y
    Neoplasia; 2021 Dec; 23(12):1204-1212. PubMed ID: 34735995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the spatiotemporal genetic heterogeneity in metastatic lung adenocarcinoma using a nuclei flow-sorting approach.
    Lorber T; Andor N; Dietsche T; Perrina V; Juskevicius D; Pereira K; Greer SU; Krause A; Müller DC; Savic Prince S; Lardinois D; Barrett MT; Ruiz C; Bubendorf L
    J Pathol; 2019 Feb; 247(2):199-213. PubMed ID: 30350422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of complex glandular patterns in invasive pulmonary adenocarcinomas.
    Bossé Y; Gagné A; Althakfi W; Orain M; Fiset PO; Desmeules P; Joubert P
    Hum Pathol; 2022 Oct; 128():56-68. PubMed ID: 35872155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonpredominant lepidic pattern correlates with better outcome in invasive lung adenocarcinoma.
    Mäkinen JM; Laitakari K; Johnson S; Mäkitaro R; Bloigu R; Lappi-Blanco E; Kaarteenaho R
    Lung Cancer; 2015 Dec; 90(3):568-74. PubMed ID: 26506915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of malignant grade between pure and partially invasive types of early lung adenocarcinoma.
    Sasada S; Nakayama H; Miyata Y; Tsubokawa N; Mimae T; Yoshiya T; Murakami S; Ito H; Okada M
    Ann Thorac Surg; 2015 Mar; 99(3):956-60. PubMed ID: 25620597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thoracic
    Xiong Y; Zhang B; Nie LG; Wu SK; Zhao H; Li D; DI JT
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):351-356. PubMed ID: 37042149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of lung adenocarcinoma second predominant pattern from a large European database.
    Bertoglio P; Querzoli G; Ventura L; Aprile V; Cattoni MA; Nachira D; Lococo F; Rodriguez Perez M; Guerrera F; Minervini F; Gnetti L; Bacchin D; Franzi F; Rindi G; Bellafiore S; Femia F; Viti A; Bogina GS; Kestenholz P; Ruffini E; Paci M; Margaritora S; Imperatori AS; Lucchi M; Ampollini L; Terzi AC
    J Surg Oncol; 2021 Feb; 123(2):560-569. PubMed ID: 33169397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.
    Sun PL; Seol H; Lee HJ; Yoo SB; Kim H; Xu X; Jheon S; Lee CT; Lee JS; Chung JH
    J Thorac Oncol; 2012 Feb; 7(2):323-30. PubMed ID: 22237264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.